A multivariate analysis of patients with glioma: A treatment outcome and prognostic factor for survival

Journal of the Medical Association of Thailand

Volumn 91, Issue 4, 2008, Pages 491-496

  Siangprasertkij, Chaiyot ^a   Navalitloha, Yot ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Glioma; Survival; Treatment outcome

Indexed keywords

TEMOZOLOMIDE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER SURGERY; CANCER SURVIVAL; CHILD; CONFIDENCE INTERVAL; FEMALE; FOLLOW UP; GLIOMA; HUMAN; INFANT; KARNOFSKY PERFORMANCE STATUS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; OPERATION DURATION; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PROGNOSIS; STATISTICAL SIGNIFICANCE; SURGICAL RISK; SURVIVAL TIME; TREATMENT OUTCOME; TUMOR LOCALIZATION; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, ALKYLATING; CHILD; CHILD, PRESCHOOL; DACARBAZINE; FEMALE; GLIOMA; HEALTH STATUS INDICATORS; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; TREATMENT OUTCOME;

EID: 44249112147     PISSN: 01252208     EISSN: 01252208     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Central Brain Tumor Registry of the United States (CBTRUS). Statistical report: primary brain tumors in the United States, 1997-2001. Hindale, IL: CBTRUS; 2004.
2. Kleihues P, Burger PC, Scheithauer BW. The new WHO classification of brain tumours. Brain Pathol 1993; 3: 255-68.
3. Svien HJ, Mabon RF, Kernohan JW, Adson AW. Astrocytomas. Proc Staff Meet Mayo Clin 1949; 24: 54-63.
4. Ashby LS, Ryken TC. Management of malignant glioma: steady progress with multimodal approaches. Neurosurg Focus 2006; 20: E3.
5. Burger PC, Vogel FS, Green SB, Strike TA. Glioblastoma multiforme and anaplastic astrocytoma. Pathologic criteria and prognostic implications. Cancer 1985; 56: 1106-11.
6. Pignatti F, van den BM, Curran D, Debruyne C, Sylvester R, Therasse P, et al. Prognostic factors for survival in adult patients with cerebral low-grade glioma. J Clin Oncol 2002; 20: 2076-84.
7. Curran WJ Jr, Scott CB, Horton J, Nelson JS, Weinstein AS, Fischbach AJ, et al. Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst 1993; 85: 704-10.
8. Lacroix M, Abi-Said D, Fourney DR, Gokaslan ZL, Shi W, DeMonte F, et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 2001; 95: 190-8.
9. Tortosa A, Vinolas N, Villa S, Verger E, Gil JM, Brell M, et al. Prognostic implication of clinical, radiologic, and pathologic features in patients with anaplastic gliomas. Cancer 2003; 97: 1063-71.
10. Sawaya R, Hammoud M, Schoppa D, Hess KR, Wu SZ, Shi WM, et al. Neurosurgical outcomes in a modern series of 400 craniotomies for treatment of parenchymal tumors. Neurosurgery 1998; 42: 1044-55.
11. Shaw E, Arusell R, Scheithauer B, O'Fallon J, O'Neill B, Dinapoli R, et al. Prospective randomized trial of low- versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group study. J Clin Oncol 2002; 20: 2267-76.
12. Stark AM, Hedderich J, Held-Feindt J, Mehdorn HM. Glioblastoma - the consequences of advanced patient age on treatment and survival. Neurosurg Rev 2007; 30: 56-61.
13. Forsyth PA, Shaw EG, Scheithauer BW, O'Fallon JR, Layton DD Jr, Katzmann JA. Supratentorial pilocytic astrocytomas. A clinicopathologic, prognostic, and flow cytometric study of 51 patients. Cancer 1993; 72: 1335-42.
14. Giannini C, Scheithauer BW, Burger PC, Brat DJ, Wollan PC, Lach B, et al. Pleomorphic xanthoastrocytoma: what do we really know about it? Cancer 1999; 85: 2033-45.
15. Shepherd CW, Scheithauer BW, Gomez MR, Altermatt HJ, Katzmann JA. Subependymal giant cell astrocytoma: a clinical, pathological, and flow cytometric study. Neurosurgery 1991; 28: 864-8.
16. Lote K, Egeland T, Hager B, Stenwig B, Skullerud K, Berg-Johnsen J, et al. Survival, prognostic factors, and therapeutic efficacy in low-grade glioma: a retrospective study in 379 patients. J Clin Oncol 1997; 15: 3129-40.
17. Nomiya T, Nemoto K, Kumabe T, Takai Y, Yamada S. Prognostic significance of surgery and radiation therapy in cases of anaplastic astrocytoma: retrospective analysis of 170 cases. J Neurosurg 2007; 106: 575-81.
18. Vecht CJ, Avezaat CJ, van Putten WL, Eijkenboom WM, Stefanko SZ. The influence of the extent of surgery on the neurological function and survival in malignant glioma. A retrospective analysis in 243 patients. J Neurol Neurosurg Psychiatry 1990; 53: 466-71.
19. Jeremic B, Milicic B, Grujicic D, Dagovic A, Aleksandrovic J. Multivariate analysis of clinical prognostic factors in patients with glioblastoma multiforme treated with a combined modality approach. J Cancer Res Clin Oncol 2003; 129: 477-84.
20. Hoshino T, Prados M, Wilson CB, Cho KG, Lee KS, Davis RL. Prognostic implications of the bromodeoxyuridine labeling index of human gliomas. J Neurosurg 1989; 71: 335-41.
21. Hoshino T. A commentary on the biology and growth kinetics of low-grade and high-grade gliomas. J Neurosurg 1984; 61: 895-900.
22. Albert FK, Forsting M, Sartor K, Adams HP, Kunze S. Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis. Neurosurgery 1994; 34: 45-60.
23. Kowalczuk A, MacDonald RL, Amidei C, Dohrmann G III, Erickson RK, Hekmatpanah J, et al. Quantitative imaging study of extent of surgical resection and prognosis of malignant astrocytomas. Neurosurgery 1997; 41: 1028-36.
24. Galmarini CM, Galmarini FC. Multidrug resistance in cancer therapy: role of the microenvironment. Curr Opin Investig Drugs 2003; 4: 1416-21.
25. Groothuis DR, Vriesendorp FJ, Kupfer B, Warnke PC, Lapin GD, Kuruvilla A, et al. Quantitative measurements of capillary transport in human brain tumors by computed tomography. Ann Neurol 1991; 30: 581-8.